Figure 4.
Pathogen distribution and infection patterns in SCAP versus nsCAP patients. (A) Differences in pathogen detection rates between SCAP and nsCAP patients (only pathogens with detection rates ≥0.1% are shown, complete results are shown in Supplementary Figure 7). (B) Spearman correlation analysis between the detection of 25 clinically significant pathogens and clinical features. (C) Difference in M. pneumoniae normalized read counts between SCAP and nsCAP patients. (D) Multivariable-adjusted logistic regression analysis of SCAP versus nsCAP patients (only factors with p-value <0.05 are shown).
